What it is
Epithalon (usually written Epitalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly, often abbreviated AEDG. It was designed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology to mimic the active fragment of epithalamin, a natural peptide extract from the pineal gland.
The pineal gland regulates melatonin and circadian rhythms, and it shrinks with age. The original idea was that a peptide bioregulator derived from it might counter age-related decline. Epitalon is the lab-made, defined-sequence version of that messy glandular extract.
It is sold as a lyophilized (freeze-dried) powder labeled 'for laboratory research use only.' It is not an approved medicine anywhere, and nothing here is dosing or medical advice.
How it works
The headline claimed mechanism is telomerase activation. Telomeres are protective caps on chromosomes that shorten with each cell division; telomerase is the enzyme that can rebuild them. In cell-culture work, Khavinson's group reported that Epitalon switched telomerase back on in human cells and lengthened telomeres. The theory is that by maintaining telomere length, it could slow cellular aging — but this is a hypothesis extrapolated from lab dishes, not a proven effect in living people.
A second proposed route is neuroendocrine: Epitalon is theorized to normalize melatonin production and circadian rhythms, which decline with age, and to have antioxidant and antimutagenic effects. These mechanisms are plausible on paper and supported mostly by animal and in-vitro data; how much of any of it translates to human aging outcomes remains unproven.
What people research it for
Telomerase activation and telomere lengthening
Preclinical / theorizedReactivated telomerase and elongated telomeres in cultured human cells in the foundational studies.
Reduced mortality in elderly cohorts
Early human dataRussian follow-up studies of pineal peptides reported lower all-cause and cardiovascular mortality in older adults — striking claims, but from a single research group.
Melatonin and circadian rhythm normalization
Early human dataReported to restore age-disrupted melatonin secretion and sleep-wake rhythms.
Antioxidant and geroprotective effects
Animal studiesReduced oxidative and age-related damage and extended lifespan in rodents, flies, and cell models.
What the research actually shows
The scientific case rests heavily on Khavinson's group. A 2003 cell-culture paper (Khavinson et al., Bull Exp Biol Med) reported that Epitalon induced telomerase activity and telomere elongation in human somatic cells. Separately, human cohort work on the parent extract epithalamin reported a roughly 1.6–1.8-fold reduction in mortality over 6 years in ~266 older adults, and a 15-year cardiovascular follow-up reported lower mortality and better metabolic and circadian markers in treated elderly coronary patients.
The crucial caveat: nearly all of this comes from one Russian institute, spanning older and sometimes small studies, often published in a limited set of journals and not widely replicated by independent Western labs. A 2025 review (Int J Mol Sci) called the compound bioactive and promising but noted physicochemical and structural data remain limited.
In short, the findings are real publications, not fabrications — but the evidence base is narrow, largely single-group, and far from the standard of replicated, large randomized trials that would justify the 'proven longevity drug' framing common in marketing.
Research handling & storage
In research settings Epitalon is supplied as a lyophilized powder, typically reconstituted with bacteriostatic or sterile water. The powder is generally stored frozen or refrigerated and kept away from light; once reconstituted it is refrigerated and used within a limited window. As with any peptide, it is sensitive to heat, repeated freeze-thaw cycles, and moisture.
Peptides like this have a short circulating half-life (on the order of minutes to a couple of hours), which is why the Russian protocols historically used short courses given in cycles rather than continuous dosing. Any protocol details in the literature are research context, not a usage recommendation.
Safety & cautions
Human safety data are limited. The published studies reported few adverse effects at the doses used, but they were small, mostly single-group, and not designed as rigorous long-term safety trials. There is no regulatory safety review behind this compound.
The most cited theoretical concern follows directly from its proposed mechanism: anything that activates telomerase could, in principle, also support the survival of abnormal or pre-cancerous cells, since many cancers exploit telomerase. This is a theoretical risk, not a demonstrated one, but it is the reason to be cautious about an unapproved telomerase-modulating peptide taken outside medical supervision.
Track Epithalon prices
Get an alert when a trusted, tested vendor drops the price. Free.
Frequently asked questions
Is Epithalon FDA approved?
No. It is not approved by the FDA or other major regulators for any use. It is sold strictly as a research chemical 'for laboratory use only,' not as a medicine or supplement.
Does it really extend lifespan?
In animals and cell studies it has extended lifespan, and Russian human cohort data reported lower mortality in the elderly. But those human results are from a single research group, older, and not independently replicated in large trials — so 'it extends human lifespan' is unproven, not established.
Does it lengthen telomeres in people?
Telomere lengthening was shown in cultured human cells. Whether it meaningfully lengthens telomeres in living humans, and whether that would translate to health benefits, has not been convincingly demonstrated.
Is Epitalon the same as epithalamin?
Not exactly. Epithalamin is a natural pineal extract; Epitalon is a synthetic, single-sequence tetrapeptide designed to represent its active portion. Much of the human mortality data is actually on epithalamin, the extract.
Are there safety risks?
Safety data are thin. The main theoretical concern is that telomerase activation could support abnormal cell survival, a mechanism relevant to cancer. It is unapproved and not medically supervised, which adds risk.
Sources
- Khavinson et al. 2003 — Epithalon induces telomerase activity and telomere elongation in human somatic cells (Bull Exp Biol Med)
- Khavinson & Morozov 2003 — Peptides of pineal gland and thymus prolong human life (Neuro Endocrinol Lett)
- Korkushko, Khavinson et al. 2011 — Peptide geroprotector, 15-year follow-up in elderly (Bull Exp Biol Med)
- Araj et al. 2025 — Overview of Epitalon, Highly Bioactive Pineal Tetrapeptide (Int J Mol Sci)
Last reviewed 2026-07-07. This guide is educational and research-focused — not medical advice. Epithalon products referenced on PeptidePub are sold by third parties as materials for laboratory research use only, not for human or animal consumption.
Related peptides
Ready to compare Epithalon?
See prices across trusted, third-party-tested vendors, normalized per milligram.
Compare Epithalon prices →